Attana at PEGS 2010- the essential protein engineering summit

Event date 17 May 2010 02:00 – 21 May 2010 05:00

Location Sheraton Boston Hotel, Boston Massachusetts

Staffan Grenklo Ph.D, Cell Biologist, Attana AB Presentation focus: In today’s quest for new therapeutic drugs, it is increasingly important to obtain early and informative data on potential agents in order to save time and costs. Combining biosensor technologies contributing to detailed information on molecular interactions with an experimental approach, as close as possible to the natural environment of action, increases the chances of selecting the optimal candidate already in the pre-clinical phase. Track: Pre-clinical/ clinical development of Antibodies, Wed May 19th http://www.pegsummit.com/

Categories

  • pegs 2010
  • attana cell 200
  • attana
  • biosensor
  • kinetic on cells
  • qcm

Contacts

Related content

  • Attana AB launches new software suite

    Attana is proud to announce the release of Attaché 2.0, a powerful new software suite developed in collaboration with Ridgeview Instruments AB.

  • Biosensor- Attana Cell 200, label free, real time kinetics on cells

    Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

  • Attana's core business!

    View article in Innovations in Pharmaceutical Technology (IPT), a brief overview of Attana's core business. http://www.iptonline.com/viewinn.asp?cat=2&article=285

  • Characterisation of complex lectin-cell kinetics (Attana Application Example)

    Attana Cell 200 - Label free, real time kinetics on cells, exploring biology on a new level!
     
    In the development process of new pharmaceutical compounds, kinetic experiments provide insights
    into potential drug candidates while also defining lead targets. In this application example we demonstrate the ability of the Attana Cell™ 200 to provide a complete and highly relevant analysis of a

Related events

Enter your email address to follow Attana AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Attana AB.

Okay